| Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study A Ghaleiha, N Entezari, A Modabbernia, B Najand, N Askari, M Tabrizi, ... Journal of psychiatric research 47 (2), 175-180, 2013 | 198 | 2013 |
| Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial A Ghaleiha, M Asadabadi, MR Mohammadi, M Shahei, M Tabrizi, ... International Journal of Neuropsychopharmacology 16 (4), 783-789, 2013 | 151 | 2013 |
| Crocus sativus L. versus citalopram in the treatment of major depressive disorder with anxious distress: a double-blind, controlled clinical trial A Ghajar, SM Neishabouri, N Velayati, L Jahangard, N Matinnia, ... Pharmacopsychiatry 50 (04), 152-160, 2017 | 142 | 2017 |
| Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia: an 8-week, randomized, double-blind, placebo-controlled study A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ... CNS drugs 27 (1), 57-65, 2013 | 141 | 2013 |
| Pioglitazone adjunctive therapy for depressive episode of bipolar disorder: a randomized, double‐blind, placebo‐controlled trial A Zeinoddini, M Sorayani, E Hassanzadeh, M Arbabi, M Farokhnia, ... Depression and anxiety 32 (3), 167-173, 2015 | 127 | 2015 |
| Prevalence of depression and its associated sociodemographic factors among Iranian female adolescents in secondary schools B Moeini, S Bashirian, AR Soltanian, A Ghaleiha, M Taheri BMC psychology 7 (1), 25, 2019 | 116 | 2019 |
| Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ... Bipolar disorders 17 (6), 606-614, 2015 | 110 | 2015 |
| Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial A Ghaleiha, M Ghyasvand, MR Mohammadi, M Farokhnia, N Yadegari, ... Journal of Psychopharmacology 28 (7), 677-685, 2014 | 96 | 2014 |
| Training emotional intelligence improves both emotional intelligence and depressive symptoms in inpatients with borderline personality disorder and depression L Jahangard, M Haghighi, H Bajoghli, M Ahmadpanah, A Ghaleiha, ... International Journal of Psychiatry in Clinical Practice 16 (3), 197-204, 2012 | 89 | 2012 |
| Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double‐blind, randomized, and placebo‐controlled trial M Ghiasian, F Khamisabadi, N Kheiripour, M Karami, R Haddadi, ... Journal of Biochemical and Molecular Toxicology 33 (12), e22410, 2019 | 87 | 2019 |
| In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder L Jahangard, S Soroush, M Haghighi, A Ghaleiha, H Bajoghli, ... European Neuropsychopharmacology 24 (8), 1210-1221, 2014 | 79 | 2014 |
| The prevalence of psychiatric distress and associated risk factors among college students using GHQ-28 questionnaire J Poorolajal, A Ghaleiha, N Darvishi, S Daryaei, S Panahi Iranian journal of public health 46 (7), 957, 2017 | 78 | 2017 |
| Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial M Ghazizadeh-Hashemi, A Ghajar, MR Shalbafan, ... Journal of affective disorders 232, 127-133, 2018 | 74 | 2018 |
| A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism A Ghaleiha, SM Rasa, M Nikoo, M Farokhnia, MR Mohammadi, ... Psychiatry research 229 (1-2), 181-187, 2015 | 70 | 2015 |
| Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial A Ghaleiha, E Mohammadi, MR Mohammadi, M Farokhnia, ... Pediatric Drugs 15 (6), 505-514, 2013 | 70 | 2013 |
| Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: R andomized, double‐blind, placebo‐controlled study S Emamzadehfard, A Kamaloo, K Paydary, A Ahmadipour, A Zeinoddini, ... Psychiatry and Clinical Neurosciences 70 (8), 332-341, 2016 | 68 | 2016 |
| Double‐blind randomized parallel‐group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression R Abolfazli, M Hosseini, A Ghanizadeh, A Ghaleiha, M Tabrizi, ... Depression and anxiety 28 (4), 297-302, 2011 | 67 | 2011 |
| Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial A Ghaleiha, H Davari, L Jahangard, M Haghighi, M Ahmadpanah, ... European archives of psychiatry and clinical neuroscience 266 (8), 695-702, 2016 | 66 | 2016 |
| Crocus sativus L.(saffron) versus sertraline on symptoms of depression among older people with major depressive disorders–a double-blind, randomized intervention study M Ahmadpanah, F Ramezanshams, A Ghaleiha, S Akhondzadeh, ... Psychiatry research 282, 112613, 2019 | 62 | 2019 |
| Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial A Ghaleiha, R Alikhani, MR Kazemi, MR Mohammadi, ... Journal of child and adolescent psychopharmacology 26 (9), 784-791, 2016 | 59 | 2016 |
Shahin AkhondzadehPsychiatric Research Center, Roozbeh Hospital, Tehran University of Medical Sciences, IranVerified email at neda.net
